Senior Oncology Account Specialist Hematology Dallas, TX

Responsibilities Promote Pfizer’s oncology product portfolio to healthcare providers and specialists. Educate members of the healthcare community on appropriate use of Pfizer products. Call on accounts and organized customers to improve patients’ experience and overall quality of patient care. Increase Pfizer’s brand with high-value target customers by assessing the account/business landscape and leveraging Pfizer products/resources. Basic Qualifications BA/BS from an accredited institution OR associate’s degree with 8+ years experience OR high school diploma (or equivalent) with 10+ years relevant experience. Ability to travel domestically and stay overnight as necessary. Valid US driver’s license; no DUI/DWI or other impaired driving citation within the past 7 years. Minimum 4 years pharmaceutical sales experience OR 4 years oncology HCP experience working with key oncology thought leaders/high-influence customers (hospitals, large group practices, or managed care). Demonstrated track record of success. Ability to communicate technical/scientific product and disease-management information. Strong business acumen. Proficiency with complex digital applications and ability to adapt to Pfizer’s technology model. Preferred Qualifications 3–5 years oncology sales experience; experience in hematology. Master’s degree and/or advanced HCP degree. Experience calling on institutions, NCI centers, and Key Opinion Leaders. Functional/Technical Skills Promote broad portfolio; strong knowledge of disease states/therapeutic areas/products. Strategic territory/account/customer planning; generate demand in assigned accounts. Maintain and expand relationships across institutions; cultivate KOL relationships. Benefits/Compensation (as stated) Base salary range: $101,500–$245,400; sales incentive bonus; 401(k) with Pfizer matching and retirement contribution; paid vacation/holidays/personal days; paid caregiver/parental and medical leave; medical/prescription/dental/vision. Application Instructions Last day to apply: June 4, 2026. #J-18808-Ljbffr Scorpion Therapeutics